Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Molecular Oncology|October 23, 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastomaSrinivas Chava, C Patrick Reynolds, Anup S Pathania, et al.
AIDS (London, England)|July 25, 2012
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized micePrasanta K Dash, Howard E Gendelman, Upal Roy, et al.
Advanced Drug Delivery Reviews|November 14, 2018
Neurotheranostics as personalized medicinesBhavesh D Kevadiya, Brendan M Ottemann, Midhun Ben Thomas, et al.
Glia|May 18, 2006
Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brainHuanyu Dou, Justin Morehead, Jennifer Bradley, et al.
Research Square|July 9, 2025
CEST MRI Affirms HIV-1-Associated Neurometabolic Impairments in a Humanized Mouse ModelGabriel C Gauthier, Micah Summerlin, Balasrinivasa R Sajja, et al.
Neuroimmune Pharmacology and Therapeutics|May 1, 2025
HIV-1 infection facilitates Alzheimer's disease pathology in humanized APP knock-in immunodeficient miceShaurav Bhattarai, Rana Kadry, Pravin Yeapuri, et al.
Seminars in Cancer Biology|December 3, 2017
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspectivePalanisamy Nallasamy, Srinivas Chava, Sumit S Verma, et al.
Molecular Neurobiology|June 12, 2015
Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized MiceAditya N Bade, Santhi Gorantla, Prasanta K Dash, et al.
Journal of Neuroimmunology|June 23, 2009
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disordersDawn Eggert, Prasanta K Dash, Nawal Serradji, et al.
Research Square|June 17, 2024
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral ActivitiesHoward E Gendelman, Milankumar Patel, Sudipta Panja, et al.
Pageof 11